Home » Newsletters » BioWorld Science

BioWorld Science

July 19, 1999

View Archived Issues

Amprenavir and other PIs affect fat mass and lipid levels

ViroPharma announces successful VRI program with pleconaril

Tanox tests Hu-901 in peanut allergy

Gabapentin found to reduce symptoms of social anxiety disorder

Interim data released for NeoRx's STR product in multiple myeloma

MPBX's enhancement of doxorubicin activity examined in P388 leukemia

Guerbet discloses new imaging agents

Naturally produced depsipeptides found to possess antibacterial and antiinflammatory activity

Aastrom Biosciences receives SBIR grant for Aastrom Replicell system

Preliminary findings reported for combination HIV vaccine

MTP and/or ApoB secretion inhibitors synthesized at Pfizer

Inhibitors of caspases undergo joint development at Warner-Lambert and BASF

Xanthines acting as inhibitors of PDE4 and/or TNF claimed by Darwin Discovery

Triazine-based inhibitors of angiogenesis designed by Abbott researchers

Ligands for histamine H3 receptors in the pipeline at Sanofi-Synthelabo

Intranasal apomorphine to enter efficacy studies for erectile dysfunction by year end

FDA clears pioglitazone for type II diabetes

Genentech announces R&D highlights from second quarter

PDT with Photofrin cleared in Canada for certain forms of lung cancer

Phytopharm obtains rights to Indian antihepatitis B product

Transplanted human neural stem cells migrate and differentiate

Welsh technology applicable to antiviral drug discovery licensed to Glaxo Wellcome

New cytoprotective compound that acts by inhibiting PARP activity developed at N-Gene

HCV-specific antisense oligonucleotide undergoing advanced preclinical studies at Isis

MGI Pharma to copromote rheumatology product with Pharmacia & Upjohn

Preclinical activity, current status of potent P-glycoprotein inhibitor discussed at congress

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...